Harbour Investments, Inc. Chemo Centryx, Inc. Transaction History

Harbour Investments, Inc.

$3.14 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 16, 2022	SELL	$18.38 - $40.5 $1,488 - $3,280	-81 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $434 - $654	33 Added 68.75%	81 $1,000
Q2 2021 Aug 16, 2021	SELL	$9.59 - $50.88 $9 - $50	-1 Reduced 2.04%	48 $1,000
Q1 2021 Aug 17, 2021	BUY	$49.53 - $68.4 $2,426 - $3,351	49 New	49 $3,000
Q1 2021 May 12, 2021	BUY	$49.53 - $68.4 $0 - $0	0 New	0 $0

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.